- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zenas Biopharma Inc (ZBIO)
Zenas Biopharma Inc stock price live, this page displays NASDAQ ZBIO stock exchange data. View the ZBIO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zenas Biopharma Inc real time stock price chart below.
What Is the Zenas Biopharma Inc Stock Price Today?
The Zenas Biopharma Inc stock price today is 27.67.
What Is the Stock Symbol for Zenas Biopharma Inc?
The stock symbol for Zenas Biopharma Inc is "ZBIO."
What Stock Exchange Does Zenas Biopharma Inc Trade On?
Zenas Biopharma Inc is listed and trades on the NASDAQ stock exchange.
Is Zenas Biopharma Inc a Good Stock to Buy?
Determining whether Zenas Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZBIO quote. (ISIN: US98937L1052)
What Is the Zenas Biopharma Inc Stock Price Today?
The Zenas Biopharma Inc stock price today is 27.67.
What Is the Stock Symbol for Zenas Biopharma Inc?
The stock symbol for Zenas Biopharma Inc is "ZBIO."
What Stock Exchange Does Zenas Biopharma Inc Trade On?
Zenas Biopharma Inc is listed and trades on the NASDAQ stock exchange.
Is Zenas Biopharma Inc a Good Stock to Buy?
Determining whether Zenas Biopharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ZBIO quote. (ISIN: US98937L1052)
27.67
+0.72(+2.65%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.47
27.78
52 wk Range
13.50
44.60
ZBIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.4727.78
52 wk Range
13.5044.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ZBIO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
47.00
Upside
+69.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 47.00
(+69.86% Upside)
Earnings
Latest Release
Aug 13, 2026
EPS / Forecast
-1.77 / --
Revenue / Forecast
1M / --
Compare ZBIO to Peers and Sector
Metrics to compare | ZBIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZBIOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.6x | −1.5x | −0.4x | |
PEG Ratio | 0.05 | −0.05 | 0.00 | |
Price/Book | 7.1x | 2.3x | 2.6x | |
Price / LTM Sales | 1,746.1x | 96.9x | 3.1x | |
Upside (Analyst Target) | 74.4% | 331.5% | 57.4% | |
Fair Value Upside | Unlock | 15.6% | 7.7% | Unlock |
Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a CTLA-4-Ig fusion protein designed to have an extended half-life versus; and ZB001, an anti-IGF-1R monoclonal antibody. The company was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is headquartered in Waltham, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Zenas Biopharma (ZBIO) Stock Price Today?
The Zenas Biopharma stock price today is 27.67 USD.
What Stock Exchange Does Zenas Biopharma Trade On?
Zenas Biopharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Zenas Biopharma?
The stock symbol for Zenas Biopharma is "ZBIO."
What Is the Zenas Biopharma Market Cap?
As of today, Zenas Biopharma market cap is 1.76B USD.
What Is Zenas Biopharma's Earnings Per Share (TTM)?
The Zenas Biopharma EPS (TTM) is -9.05.
When Is the Next Zenas Biopharma Earnings Date?
Zenas Biopharma will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is ZBIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Zenas Biopharma Stock Split?
Zenas Biopharma has split 0 times.
How Many Employees Does Zenas Biopharma Have?
Zenas Biopharma has 167 employees.
What is the current trading status of Zenas Biopharma (ZBIO)?
As of Sep 28, 2026, Zenas Biopharma (ZBIO) is trading at a price of 27.67 USD, with a previous close of 26.95 USD. The stock has fluctuated within a day range of 26.47 USD to 27.78 USD, while its 52-week range spans from 13.50 USD to 44.60 USD.
What Is Zenas Biopharma (ZBIO) Price Target According to Analysts?
The average 12-month price target for Zenas Biopharma is 47.00 USD, with a high estimate of 59 USD and a low estimate of 32 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +69.86% Upside potential.
What Is the ZBIO Premarket Price?
ZBIO's last pre-market stock price is 27.16 USD. The pre-market share volume is 10.00, and the stock has decreased by 0.21, or 0.78%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.